Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.41 |
| ▸ | HRH1 | P35367 | 2/20 | 0.40 |
| ▸ | HRH2 | P25021 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8634057 | 0.99 | CYP2C9 (0.43) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8633634 | 0.86 | CYP2C9 (0.46) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8630430 | 0.83 | ITGB3 (0.45) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8635833 | 0.81 | CYP2C9 (0.45) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| Hydrochloric Acid SCHEMBL8681089 | 0.80 | CYP2C9 (0.44) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8635264 | 0.80 | CYP2C9 (0.44) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| Hydrochloric Acid SCHEMBL8637474 | 0.80 | CYP2C9 (0.44) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8630604 | 0.79 | CYP2C9 (0.43) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8632705 | 0.78 | CYP2C9 (0.42) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR | |
| SCHEMBL8631971 | 0.76 | ITGB3 (0.40) | CYP2C9SMN1; SMN2ALDH1A1CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5753659-A | ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, | ZENECA LIMITED (GB) | 1998-05-19 | — | — | US | disclosed |
| US-5750754-A | TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS | ZENECA LIMITED (GB) | 1998-05-12 | — | — | US | disclosed |
| US-5728701-A | INHIBIT PLATELET AGGREGATION | ZENECA LIMITED (GB) | 1998-03-17 | — | — | US | disclosed |